[ASND] YoY Quarter Result on 30-Sep-2018 [#Q3]

Stock
[ASND] Ascendis Pharma A/S
Announcement Date
29-Aug-2018
Financial Year
2018
Quarter
30-Sep-2018 [#Q3]
Profit Trend
QoQ- -49.13%
YoY- -0.27%
Quarter Report
ASND's Result
ASND's Financial Summary
View:
Show?
Quarter Result
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
Revenue 1,113 2,757 2,243 20 434 1,169 2,117 -10.15%
PBT -80,343 -121,760 -25,174 -34,067 -34,117 -18,311 -7,470 48.51%
Tax 5 -19 -61 -100 -240 -57 -160 -
NP -80,348 -121,741 -25,113 -33,967 -33,877 -18,254 -7,310 49.05%
Tax Rate - - - - - - - -
Total Cost 81,461 124,498 27,356 33,987 34,311 19,423 9,427 43.20%
Ratio Analysis
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
NP Margin -7,219.05 -4,415.71 -1,119.62 -169,835.00 -7,805.76 -1,561.51 -345.30 65.90%
Per Share
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
EPS -1.47 -2.31 -0.53 -0.81 -1.04 -0.72 -0.30 30.29%
EPS Diluted -1.47 -2.31 -0.53 -0.81 -1.04 -0.72 -0.30 30.29%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.